On Thursday 7th December, The Eve Appeal will be holding their annual Festival of Carols at the beautiful church of St. Botolph-without-Bishopsgate, right in the heart of London.
This truly magical event brings everyone together to celebrate the festive season and remember the women and families who have been and are affected by gynaecological cancers.
The Service features a candlelit procession, traditional Christmas readings and some favourite carols. Festivities will then continue at the Reception where guests can enjoy canapés, wine and mince pies whilst mingling with Eve supporters, staff and trustees.
Time and date: 07/12/17 | 18.30-21.30
Location: St. Botolph-without-Bishopsgate, Bishopsgate, London, EC2M 3TL
Price: Service only – £14
Service and Reception – £32
There is also the option to become a Christmas Angel and have your name included in the Festival of Carols programme by making an additional donation of £50. Please note that tickets to the Service and/or Reception are not included within this £50 donation and must be purchased separately.
Tickets can be purchased via The Eve Appeal’s website or by giving the Eve Team a call on 020 7605 0100.
About The Eve Appeal
The Eve Appeal is the only UK national charity raising awareness and funding research in the five gynaecological cancers – ovarian, womb, cervical, vaginal and vulval. It was set up to save women’s lives by funding ground-breaking research focused on developing effective methods of risk prediction, earlier detection and developing screening for these women-only cancers. The charity has grown and developed in parallel with its core research team, the Department of Women’s Cancer at University College London (UCL), taking place in 31 institutions across 15 countries. It has played a crucial role in providing seed funding, core infrastructure funding and project funding in addition to campaigning to raise awareness of women-specific cancers. The world-leading research that we fund is ambitious and challenging but our vision is simple: A future where fewer women develop and more women survive gynaecological cancers.